Iecure Raises $65 Million To Advance In Vivo Gene Editing Programs For The Treatment Of Rare Pediatric Liver Diseases
Amount Raised
$65 Million
Round Type
Funding Round
PhiladelphiaBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
iECURE, a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies for the treatment of liver disorders with significant unmet need, announced today the completion of a $65 million Series A-1 financing. The Series A-1 financing was co-led by Novo Holdings A/S and LYFE Capital with significant participation from existing investors Versant Ventures and OrbiMed Advisors.
Quick answer
iECURE raised $65 Million in a Funding Round round, dated November 30, 2022. Investors: Novo Ventures, Versant Ventures, LYFE Capital and Novo Holdings A/S. iECURE is based in Philadelphia, Pennsylvania, United States.
- How much did iECURE raise?
- iECURE raised $65 Million in a Funding Round round on November 30, 2022.
- Who invested in iECURE?
- Novo Ventures, Versant Ventures, LYFE Capital and Novo Holdings A/S are named as investors in this round.
- What does iECURE do?
- iECURE is a gene editing company focused on developing therapies that utilize mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need.
- Where is iECURE based and how big is it?
- iECURE is based in Philadelphia, Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as iECURE that raised within 45 days of this round, from Fundz verified event records.
- Akamis Bio raised $30M (Funding Round) on January 5, 2023.
- Solid Biosciences raised $9.2M on December 2, 2022.
- MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
- Nest Genomics raised $8.5M (Seed) on January 10, 2023.
- Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
Who to call at iECURE, and when
A new round usually means iECURE is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iECURE raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iECURE, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iECURE. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iECURE raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
iECURE raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.